Not immune to modification. by Hesser, Charles R & Glaunsinger, Britt A
UC Office of the President
Recent Work
Title
Not immune to modification.
Permalink
https://escholarship.org/uc/item/31s8w96p
Journal
Nature immunology, 20(2)
ISSN
1529-2908
Authors
Hesser, Charles R
Glaunsinger, Britt A
Publication Date
2019-02-01
DOI
10.1038/s41590-018-0301-1
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
116
news & views
NaTuRE IMMuNoloGy | VOL 20 | FEBRUARY 2019 | 112–120 | www.nature.com/natureimmunology
References
 1. Zhu, P. et al. Nat. Immunol. https://doi.org/10.1038/s41590-018-
0297-6 (2018).
 2. Allaire, J. M. et al. Trends Immunol. 39, 677–696 (2018).
 3. Barker, N. et al. Nature 449, 1003–1007 (2007).
 4. van Es, J. H. et al. Mol. Cell. Biol. 32, 1918–1927 (2012).
 5. Ali, N. et al. Cell 169, 1119–1129 (2017).
 6. Naik, S. et al. Nature 550, 475–480 (2017).
 7. von Moltke, J., Ji, M., Liang, H.-E. & Locksley, R. M. Nature 529, 
221–225 (2016).
 8. Haber, A. L. et al. Nature 551, 333–339 (2017).
 9. Nusse, Y. M. et al. Nature 559, 109–113 (2018).
 10. Salzman, J. Trends Genet. 32, 309–316 (2016).
 11. Memczak, S. et al. Nature 495, 333–338 (2013).
 12. Walker, M. P. et al. Sci. Signal. 362, ra12 (2013).
 13. Biton, M. et al. Cell 175, 1307–1320 (2018).
 14. Howitt, M. R. et al. Science 351, 1329–1333  
(2016).
Competing interests
The authors declare no competing interests.
CYTOkINE RNA STAbILITY
Not immune to modification
The N6-methyladenosine (m6A) RNA-modification pathway substantially affects the outcome of viral infection. 
Studies now show that m6A modification of transcripts encoding type I interferons limits the duration of  
anti-viral signaling.
Charles R. Hesser and britt A. Glaunsinger
The function and fate of RNA can be heavily influenced by chemical alterations to its sequence; more 
than 150 such modifications exist. Classic 
examples of this include modifications  
to the wobble position of the tRNA 
anticodon loop, which contribute to 
expanded coding potential, and to the  
5′ cap structure of mRNA1. Over the past 
several years, a remarkable array of gene-
regulatory phenotypes have been ascribed 
to modification of cellular mRNA by m6A, 
the most abundant internal modification on 
these transcripts1. Published studies have 
shown that the cellular m6A machinery can 
also influence the outcome of viral infection, 
at least in part by affecting expression 
of m6A-modified viral RNA2,3. Two new 
complementary studies, by Winkler 
and colleagues in this issue of Nature 
Immunology4 and by Rubio and colleagues 
in Genes & Development5, reveal that the 
influence of the m6A pathway also extends to 
immunological regulators by demonstrating 
that transcripts encoding type I interferons 
(IFN-α and IFN-β (IFN-α /β )) — pleotropic 
mediators of anti-viral immunity — are 
also targets of m6A modification. Thus, 
inhibiting m6A modification can alter the 
outcome of infection by affecting the fate 
of both viral mRNAs and host mRNAs that 
drive anti-viral responses.
Published studies have indicated  
that m6A is an important component of 
host–pathogen interactions. For example, 
it has a critical role in regulating cellular 
transition states and maintaining T cell 
homeostasis6. A role for m6A in recognition 
by the innate immune system has also been 
proposed, as m6A-modified RNAs show 
reduced activation of Toll-like receptor 
pathways7. For these reasons, interest in 
the role of m6A in infectious contexts has 
burgeoned. While numerous studies of viral 
infection have found enrichment for m6A 
in viral transcripts, precisely how the m6A 
pathway regulates viral life cycles remains an 
active area of investigation. For hepatitis C 
virus, which has an entirely cytoplasmic life 
cycle, m6A restricts viral assembly2.  
For influenza A virus and SV40 
polyomavirus, which replicate in the 
nucleus, m6A instead promotes viral 
gene expression8,9. However, for several 
viruses with complex life cycles (human 
immunodeficiency virus, hepatitis  
B virus and Kaposi’s sarcoma–associated 
herpesvirus), a combination of pro-viral 
effects and anti-viral effects has been 
proposed2,3,10. Furthermore, the extent 
to which these phenotypes result from 
the binding of reader proteins in cis 
to methylated viral RNAs versus their 
influencing host pathways involved in the 
viral life cycle has remained unclear.
Viral infection substantially changes  
the host transcriptome, and as m6A has  
been proposed to have a role in 
‘transcriptome-turnover’ events1, its 
presence in transcripts encoding anti-viral 
cytokines could affect the innate immune 
response by accelerating their degradation. 
Indeed, anti-viral cytokines are extensively 
regulated post-transcriptionally and are 
characterized by short transcript half-lives.  
For example, AU-rich elements are present 
in 3′ untranslated regions of many cytokine-
encoding mRNAs and have a critical role 
in mRNA decay. Of particular interest in 
viral infection, IFN-α /β products induce 
resistance to viral infection but also cause a 
variety of autoimmune diseases when their 
production is dysregulated11. After being 
secreted, they exert autocrine and paracrine 
effects, binding to the IFN-α  
receptor (IFNAR) and triggering a JAK–
STAT signaling cascade that leads to the 
production of molecules encoded by 
interferon-stimulated genes (ISGs), which 
restrain viral replication via multiple 
mechanisms11. Thus, even subtle changes to 
the stability of transcripts encoding IFN-α /β  
could substantially affect the abundance 
of IFN-α /β proteins and the production 
of molecules encoded by ISGs. If m6A 
modification of transcripts encoding IFN-α /β  
contributed substantially to their post-
transcriptional decay, could this contribute 
to the pro-viral effects ascribed to the m6A 
pathway during various viral infections?
Winkler and colleagues address that 
issue by focusing on the role of m6A in host 
transcripts during infection with several 
human and mouse viruses, including human 
cytomegalovirus (HCMV), a large dsDNA 
virus that replicates in the nucleus4. Once 
installed, m6A acts as a molecular ‘beacon’ 
to recruit selective methyl-RNA-binding 
proteins known as ‘readers’. Depletion of 
either the catalytic subunit responsible for the 
installation of m6A (METTL3) or the reader 
protein YTHDF2 results in stabilization of 
the IFNB transcript and increased induction 
of downstream ISGs during infection with 
HCMV. This phenotype also develops during 
infection with each of three other human 
viruses and one mouse virus, suggestive of 
an evolutionarily conserved mechanism in 
which the m6A pathway promotes the  
decay of transcripts encoding IFN-α /β .  
In support of this hypothesis, the authors 
observe that m6A modification of transcripts 
encoding IFN-α /β is conserved across 
several human and mouse cell types and that 
viral gene expression is not required for the 
increased abundance of IFNB transcripts 
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Fig. 1 | Depletion of METTl3 or yTHDF2 enhances IFNB stability. After viral infection, double-stranded DNA is sensed, which leads to the phosphorylation and 
nuclear translocation of the transcription factors IRF3 (interferon-regulatory factor 3) and IRF7, which activate transcription of IFNB. In METTL3-deficient cells, 
no changes occur in the expression or phosphorylation of IRF3 or IRF7 and there is no initial effect on the biogenesis of IFNB mRNA. Instead, increased stability of 
transcripts encoding IFN-α /β leads to an increase in mature secreted proteins, which bind to the cognate IFN-α receptor (IFNAR); this increases activation of the 
kinase JAK1 and tyrosine kinase TYK2 and recruits proteins of the STAT family of signal transducers and activators of transcription. Increased phosphorylation 
and nuclear translocation of STAT proteins then leads to a downstream increase in the expression of ISGs. ISRE, interferon-stimulated response element.
in cells depleted of METTL3. Furthermore, 
treatment with a selective chemical inhibitor 
of the kinases required for signaling 
downstream of IFNAR largely ‘rescues’ the 
virus-replication defect in METTL3- and 
YTHDF2-deficient cells. Finally, to confirm 
that m6A modifications directly affect the 
stability of IFNB transcripts, the authors 
introduce synonymous mutations into 
the m6A consensus motifs, which results 
in greater stability of the IFNB transcripts 
commensurate to that observed after 
depletion of METTL3. Thus, the authors 
propose that depletion of m6A components 
impairs virion production mainly by 
extending the duration of IFN-α /β  
signaling (Fig. 1).
Rubio and colleagues similarly report 
regulation of the IFN-α /β response by 
the m6A pathway5. In agreement with 
the study by Winkler and colleagues4, 
they demonstrate that the m6A pathway 
modulates the IFN-α /β response in 
the absence of viral gene expression, 
which indicates that a viral protein is 
not ‘redirecting’ the m6A machinery 
away from viral transcripts to instead 
promote degradation of host transcripts. 
Both studies agree that IFNB mRNA 
is post-transcriptionally regulated by 
the m6A pathway, although Rubio and 
colleagues also observe differences in 
IFNB transcription when this pathway 
is perturbed5. Specifically, depletion 
of the m6A-methyltransferase subunit 
METTL14 increases IFNB transcription, 
while depletion of the m6A-demethylase 
ALKBH5 has the opposite effect. Although 
determining how the m6A pathway affects 
IFN-α /β induction requires further 
investigation, the increased abundance of 
IFN-α /β transcripts observed after depletion 
of METTL3 and/or METTL14 might help  
to explain published observations that the 
m6A pathway promotes certain types of  
viral infection8,9.
Modification of immunological 
regulators is only part of the effect of m6A 
during infection, however, as viral RNAs are 
frequently modified and it has been reported 
that the m6A pathway can exert pro-viral 
effects on these transcripts8,9. In these cases, 
it is possible that m6A modification of 
viral transcripts can directly increase their 
stability, perhaps via alternative functions 
of the YTHDF proteins or the activity of 
additional m6A readers. For example, the 
IGF2BP reader has been shown to promote 
the stability of m6A-modified transcripts12 
(although this has yet to be explored in viral 
infection), and the reader YTHDC1 has 
been proposed to facilitate mRNA splicing 
and export from the nucleus3 (including 
during viral infection). Furthermore, m6A 
can promote both cap-dependent translation 
and cap-independent translation, which 
might also function in viral contexts1,2. Thus, 
the m6A pathway probably influences the 
outcome of infection through cis-acting 
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effects on both viral transcripts and host 
anti-viral transcripts.
As m6A modification is dynamic and  
its distribution is enriched or altered in 
certain cell types, an ongoing challenge  
is discriminating between direct effects 
of m6A modifications and their indirect 
effects1,3. In DNA viruses, each phase of gene 
expression is dependent on the prior kinetic 
class of genes. Thus, when cells are depleted 
of writers and readers before infection, it 
is difficult to discern the relative effects on 
subsequent phases of the viral life cycle. 
While Winkler and colleagues attempt to 
minimize indirect effects by analyzing the 
distribution of m6A on HCMV transcripts at 
relatively early time points post-infection4, 
it remains possible that m6A components 
directly affect viral late gene expression, as 
has been proposed during infection with  
SV409. This possibility will be best resolved 
through the construction of viruses in which 
the m6A consensus motifs are altered to 
contain synonymous mutations.
Overall, the observation that m6A 
modification destabilizes transcripts 
encoding IFN-α /β provides important 
insight into the broad range of pro- and 
anti-viral phenotypes attributed to the 
m6A pathway and reveals new questions to 
explore. For example, while the effect on  
the stability of transcripts encoding IFN-β  
is clear, ultimately it will be important 
to address the extent to which m6A 
modifications influence the sensing of 
nucleic acids and induction of IFN-α /β .  
To this end, primary cells could be 
stimulated with a panel of nucleic acid 
agonists in the absence of m6A machinery 
to determine whether effects on the 
transcription and stability of IFNB depend 
on the stimulus used. Furthermore, 
generating and infecting mice conditionally 
deficient in specific m6A machinery could 
reveal whether cell type–specific differences 
in the distribution of m6A affect viral 
tissue tropism. If the m6A pathway broadly 
regulates the IFN-α /β response to multiple 
types of viral infection, it could serve as 
part of a conserved host response to tightly 
regulate the half-life of the transcripts 
encoding IFN-α /β , which sharpens the 
kinetics of induction and silencing to 
prevent deleterious autoimmune effects after 
viral replication has been curtailed. ❐
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IMMUNOMETAbOLISM
Metabolic requirements for expanding and 
arming a clone army
A new target for controlling T cell responses adds to the list of key processes dependent on the synthesis of 
tetrahydrobiopterin, which is essential for neurotransmitter and nitric-oxide production and pain control.
Andrew L. Mellor and Lei Huang
T cells are the ‘storm troopers’ of the immune system, since they can kill other cells. Consequently, T cells must 
be licensed, through a tightly regulated 
process, to expand their populations and 
‘bear arms’1. A study in Nature by Cronin 
et al. now reveals a critical role for the 
enzyme cofactor tetrahydrobiopterin (BH4) 
in licensing T cell clones to proliferate 
and acquire ‘weapons of destruction’2. 
These findings add to the extensive 
list of biological functions mediated 
by BH4, including the production of 
neurotransmitters and nitric oxide  
and pain control.
Circulating T cells are metabolically inert. 
After being activated, T cells proliferate 
rapidly and acquire effector functions, 
including, in the case of cytotoxic T cells, the 
ability to destroy target cells (Fig. 1). This 
licensing process has strict requirements 
for the coordinated delivery of activation 
signals from antigens, co-stimulatory 
ligands and pro-inflammatory cytokines1. 
These constraints ensure that potentially 
dangerous effector T cells are generated only 
as needed. Cronin et al. report that de novo, 
cell-intrinsic synthesis of BH4 is necessary 
for T cells to undergo clonal expansion2. 
The initial prompt is the observation that 
activated T cells express GTP cyclohydrolase 
I (GCH1), the first step in BH4 synthesis. 
The authors generate Gch1-deficient 
mice and find that activated T cells from 
these mice exhibit profound proliferative 
defects in vitro and in vivo, which confirms 
that T cell–intrinsic synthesis of BH4 
is required for efficient T cell licensing. 
This proliferative defect is highly selective 
for T cells, as ablation of Gch1 does not 
affect the development of T lymphocytes 
or B lymphocytes or the ability of B cells 
and regulatory T cells to acquire effector 
functions after being activated.
The potential clinical importance 
of BH4 emerges from mouse models 
of inflammatory colitis, allergy and 
autoimmune syndromes. In each model, 
inflammatory infiltrates and disease severity 
are substantially attenuated due to defective 
clonal expansion of T cells lacking Gch1. 
